PMID: 11907914Mar 23, 2002Paper

A systematic review of the skeletal effects of estrogen therapy in postmenopausal women. II. An assessment of treatment effects

Climacteric : the Journal of the International Menopause Society
D O'ConnellW Gillespie

Abstract

To combine the results of randomized controlled trials to provide overall estimates of the effect of estrogen treatment on fracture rates and measures of bone mass. Articles on estrogen treatment for osteoporosis published between 1977 and 1995 were identified. Studies selected were randomized controlled trials of the efficacy of estrogens in preventing loss of bone mass or fractures in postmenopausal women. Data extraction and quality assessment were performed in duplicate, with assistance of a manual. Raters were blinded as to authors and their affiliations and the publication details. With estimates of bone mass, the treatment effect size was defined as the difference in the mean annual change in bone mass between the treatment and control groups divided by the pooled standard deviation for change. In the case of fractures, efficacy was measured as the reduction in the numbers of individuals experiencing new fractures with treatment. Effect sizes were pooled using the random effects model. Thirty-seven studies met the criteria for inclusion in the systematic review. Only one small secondary prevention trial contained evaluable data on vertebral fractures. This study found a fracture relative risk of 0.63 (95% confidence inte...Continue Reading

References

Dec 1, 1977·Annals of Internal Medicine·R R ReckerR P Heaney
Feb 1, 1978·Clinical Science and Molecular Medicine·R LindsayA Kraszewski
Sep 24, 1977·British Medical Journal·A HorsmanB E Nordin
Nov 7, 1992·BMJ : British Medical Journal·J A KanisL Miravet
Jul 1, 1992·Annals of Internal Medicine·E G LufkinB L Riggs
Feb 1, 1992·American Journal of Obstetrics and Gynecology·B EttingerP Madvig
Apr 21, 1992·European Journal of Obstetrics, Gynecology, and Reproductive Biology·C Castelo-BrancoJ González-Merlo
Feb 1, 1991·The American Journal of Medicine·J C GallagherD Goldgar
Sep 15, 1991·Annals of Internal Medicine·E Barrett-Connor
Oct 1, 1991·Archives of Internal Medicine·S T HarrisR W Stoll
Oct 1, 1990·The Journal of Clinical Endocrinology and Metabolism·C Christiansen, B J Riis
Sep 1, 1990·Journal of Endocrinological Investigation·D AgnusdeiC Gennari
Aug 1, 1989·Bone and Mineral·S AdamiV Lo Cascio
Jan 22, 1987·The New England Journal of Medicine·B RiisC Christiansen
Sep 1, 1986·Controlled Clinical Trials·R DerSimonian, N Laird
Jul 1, 1985·Journal of Neuroscience Methods·H M GellerR Cooperstein
Aug 1, 1980·European Journal of Clinical Investigation·C ChristiansenI Transbøl
Aug 1, 1981·European Journal of Clinical Investigation·C ChristiansenI Transbøl
Jul 1, 1982·American Journal of Epidemiology·N KreigerT O'Connor
Jun 1, 1995·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·M GambaccianiA R Genazzani
May 1, 1995·Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research·P FilipponiS Cristallini
Feb 18, 1995·BMJ : British Medical Journal·J Windeler, S Lange
Jul 19, 1993·The Medical Journal of Australia·A H MacLennanK Eckert

❮ Previous
Next ❯

Citations

Mar 28, 2008·Archives of Pharmacal Research·Seung Min OhKyu Hyuck Chung
Jan 22, 2004·Clinica Chimica Acta; International Journal of Clinical Chemistry·Karen PazolMark E Wilson
Dec 12, 2003·Steroids·Thomas B Clarkson, Susan E Appt
Mar 1, 2003·Maturitas·Wolfgang WuttkeDana Seidlová-Wuttke
Mar 26, 2003·The Journal of Steroid Biochemistry and Molecular Biology·W WuttkeD Seidlová-Wuttke
Jul 20, 2012·The American Journal of Chinese Medicine·Wenping ZhangAtsunori Wada
May 5, 2012·BMC Medical Research Methodology·Fiona C WarrenAlex J Sutton
Sep 13, 2011·Gender Medicine·Astrid BellemGillian Einstein
May 13, 2009·Maturitas·Wolfgang WuttkeDana Seidlová-Wuttke
Apr 28, 2006·The Australian & New Zealand Journal of Obstetrics & Gynaecology·Anne W TaylorJodie C Avery
Oct 27, 2004·Endocrinology and Metabolism Clinics of North America·Susan D ReedAndrea Z Lacroix
Mar 30, 2000·American Journal of Obstetrics and Gynecology·P HadjiK D Schulz
Aug 15, 2003·Clinics in Geriatric Medicine·Lois E Wehren
Aug 31, 2002·Endocrine Reviews·George WellsUNKNOWN Osteoporosis Methodology Group and The Osteoporosis Research Advisory Group
Dec 5, 2009·Annual Review of Psychology·Tie-Yuan Zhang, Michael J Meaney
Apr 18, 2006·Proceedings. Biological Sciences·Andrew P BeckermanNils Koesters
Mar 28, 2009·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·S J Plaistow, T G Benton
Mar 28, 2009·Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences·Alexander V Badyaev, Tobias Uller
Aug 17, 2012·The Cochrane Database of Systematic Reviews·Susan FurnessAnne Lethaby
Nov 14, 2002·Drugs & Aging·Valerie Montgomery Rice

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

European Journal of Obstetrics, Gynecology, and Reproductive Biology
B R Carr
Reproduction : the Official Journal of the Society for the Study of Fertility
C H Knight, A Sorensen
BJOG : an International Journal of Obstetrics and Gynaecology
P J BlakemanJ N Bulmer
© 2022 Meta ULC. All rights reserved